WilmerHale Represents PerkinElmer in $800M Offering of Senior Notes

WilmerHale Represents PerkinElmer in $800M Offering of Senior Notes

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

On March 4, 2021, PerkinElmer, a global leader committed to innovating for a healthier world, announced its offering of $400 million of 2.550% Senior Notes due 2031 and $400 million of 3.625% Senior Notes due 2051. The company intends to use the proceeds from the offering to fund a portion of the purchase price to acquire Oxford Immunotec Global PLC, with the remainder to repay at maturity a portion of its €300 million aggregate principal amount of 0.600% senior notes due 2021. The offering priced on March 4, 2021 and closed on March 8, 2021. The joint book-running managers for the offering were J.P. Morgan Securities LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC.

The WilmerHale team representing PerkinElmer consisted of Erika Robinson, Justin Ochs, Julie Hogan Rodgers, Sean Linnehan, Chris Gravallese and Mark Devine.


Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel